Literature DB >> 20676312

Keloids: pathogenesis, clinical features, and management.

Chuma J Chike-Obi1, Patrick D Cole, Anthony E Brissett.   

Abstract

Cutaneous wound healing is a complex response to skin injury. Deregulation of this process can lead to excessive scar formation, as seen in keloids. Keloids are common skin lesions that are difficult to treat and are associated with high recurrence rates despite the large number of available treatment options. With increased knowledge of the disease process and further scientific advancements, future approaches will hopefully improve keloid treatment. In this article, we review the epidemiology, genetic basis, etiology, clinical features, pathogenesis, and management of keloids.

Entities:  

Keywords:  Keloid; hypertrophic scar; treatment

Year:  2009        PMID: 20676312      PMCID: PMC2884925          DOI: 10.1055/s-0029-1224797

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  62 in total

1.  Clinical genetics of familial keloids.

Authors:  A G Marneros; J E Norris; B R Olsen; E Reichenberger
Journal:  Arch Dermatol       Date:  2001-11

Review 2.  International clinical recommendations on scar management.

Authors:  Thomas A Mustoe; Rodney D Cooter; Michael H Gold; F D Richard Hobbs; Albert-Adrien Ramelet; Peter G Shakespeare; Maurizio Stella; Luc Téot; Fiona M Wood; Ulrich E Ziegler
Journal:  Plast Reconstr Surg       Date:  2002-08       Impact factor: 4.730

Review 3.  Lasers for scars: a review.

Authors:  Keyvan Nouri; Kelley Vidulich; Maria Patricia Rivas
Journal:  J Cosmet Dermatol       Date:  2006-03       Impact factor: 2.696

4.  Silicone versus nonsilicone gel dressings: a controlled trial.

Authors:  G V de Oliveira; T A Nunes; L A Magna; M L Cintra; G T Kitten; S Zarpellon; C M Raposo Do Amaral
Journal:  Dermatol Surg       Date:  2001-08       Impact factor: 3.398

5.  Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts.

Authors:  D V Messadi; A Le; S Berg; G Huang; W Zhuang; C N Bertolami
Journal:  Front Biosci       Date:  1998-02-15

6.  Topical mitomycin C in the prevention of keloid scar recurrence.

Authors:  Kenneth W Sanders; Linda Gage-White; Fred J Stucker
Journal:  Arch Facial Plast Surg       Date:  2005 May-Jun

7.  Mast cells: an unexpected finding in the modulation of cutaneous wound repair by charged beads.

Authors:  Aaron Sasaki; Reid V Mueller; Gong Xi; Richard Sipe; Dave Buck; Jeffrey Hollinger
Journal:  Plast Reconstr Surg       Date:  2003-04-01       Impact factor: 4.730

8.  Oxygen consumption of keloids and hypertrophic scars.

Authors:  Shigeru Ichioka; Taichi Ando; Masahiro Shibata; Naomi Sekiya; Takashi Nakatsuka
Journal:  Ann Plast Surg       Date:  2008-02       Impact factor: 1.539

9.  Differential p63 and p53 expression in human keloid fibroblasts and hypertrophic scar fibroblasts.

Authors:  Bruna De Felice; L F Ciarmiello; P Mondola; S Damiano; R Seru; C Argenziano; M Nacca; M Santoriello; C Garbi
Journal:  DNA Cell Biol       Date:  2007-08       Impact factor: 3.311

10.  Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.

Authors:  M R Duncan; B Berman
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

View more
  37 in total

1.  An important case of misdiagnosis: keloid scar or high-grade soft-tissue sarcoma?

Authors:  Rebecca Spenser Nicholas; Matthew Stodell
Journal:  BMJ Case Rep       Date:  2014-06-04

Review 2.  Dermatologic Conditions in Transgender Populations.

Authors:  Howa Yeung; Benjamin Kahn; Bao Chau Ly; Vin Tangpricha
Journal:  Endocrinol Metab Clin North Am       Date:  2019-06       Impact factor: 4.741

Review 3.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

4.  Laser fluorescence spectroscopy in predicting the formation of a keloid scar: preliminary results and the role of lipopigments.

Authors:  Andreeva Viktoriya; Raznitsyna Irina; Gerzhik Anastasiia; Glazkov Alexey; Makmatov-Rys Mikhail; Birlova Eleonora; Chursinova Yuliya; Bobrov Maksim; Rogatkin Dmitry; Sipkin Aleksandr; Kulikov Dmitry
Journal:  Biomed Opt Express       Date:  2020-03-02       Impact factor: 3.732

5.  A Randomized, Single-Blind Trial of Clobetasol Propionate 0.05% Cream Under Silicone Dressing Occlusion Versus Intra-Lesional Triamcinolone for Treatment of Keloid.

Authors:  Norazirah Md Nor; Rasimah Ismail; Adawiyah Jamil; Shamsul Azhar Shah; Farah Hani Imran
Journal:  Clin Drug Investig       Date:  2017-03       Impact factor: 2.859

6.  Risk factors of keloids in Syrians.

Authors:  Abeer Shaheen; Jamal Khaddam; Fadi Kesh
Journal:  BMC Dermatol       Date:  2016-09-20

7.  An evaluation of surgical outcome of bilateral cleft lip surgery using a modified Millard's (Fork Flap) technique.

Authors:  W L Adeyemo; O James; M O Adeyemi; M O Ogunlewe; A L Ladeinde; A Butali; O A Taiwo; C I Emeka; A O S Ayodele; C U Ugwumba
Journal:  Afr J Paediatr Surg       Date:  2013 Oct-Dec

8.  Clinical and histologic effects from CO2 laser treatment of keloids.

Authors:  Gianfranco Nicoletti; Francesco De Francesco; Carmine Michele Mele; Chiara Cataldo; Roberto Grella; Sergio Brongo; Marina Accardo; Giuseppe Andrea Ferraro; Francesco D'Andrea
Journal:  Lasers Med Sci       Date:  2012-08-21       Impact factor: 3.161

9.  Surgical management of extensive hypertrophic scarring of the halluces secondary to a decade of untreated onychocryptosis: An illustrative case report.

Authors:  Dean J Samaras; Andrew C Kingsford
Journal:  SAGE Open Med Case Rep       Date:  2017-11-06

Review 10.  Efficacy and safety of triamcinolone acetonide alone and in combination with 5-fluorouracil for treating hypertrophic scars and keloids: a systematic review and meta-analysis.

Authors:  YiMing Ren; XianHu Zhou; ZhiJian Wei; Wei Lin; BaoYou Fan; ShiQing Feng
Journal:  Int Wound J       Date:  2016-07-18       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.